Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy

Crohn’s disease (CD) and ulcerative colitis (UC) are two forms of inflammatory bowel disease (IBD), where the role of gut but not skin dysbiosis is well recognized. Inhibitors of TNF have been successful in IBD treatment, but up to a quarter of patients suffer from unpredictable skin adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiss, Zuzana, Rob, Filip, Kolar, Martin, Schierova, Dagmar, Kreisinger, Jakub, Jackova, Zuzana, Roubalova, Radka, Coufal, Stepan, Mihula, Martin, Thon, Tomas, Bajer, Lukas, Novakova, Michaela, Vasatko, Martin, Kostovcikova, Klara, Galanova, Natalie, Lukas, Milan, Kverka, Miloslav, Tresnak Hercogova, Jana, Tlaskalova-Hogenova, Helena, Jiraskova Zakostelska, Zuzana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872723/
https://www.ncbi.nlm.nih.gov/pubmed/36704107
http://dx.doi.org/10.3389/fcimb.2022.1064537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872723/
https://www.ncbi.nlm.nih.gov/pubmed/36704107
http://dx.doi.org/10.3389/fcimb.2022.1064537

Ejemplares similares